Adcock Ingram Holdings Ltd – Strategy, SWOT and Corporate Finance Report

Adcock Ingram Holdings Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Adcock Ingram Holdings Ltd (Adcock Ingram) develops, distributes and markets a wide range of healthcare products. The company’s product portfolio includes consumer and over-the-counter (OTC) products; prescription products; and generic medicines. It provides medicines in the areas of cardiovascular, central nervous system, cough, cold and flu, skin care, diabetes, ear, nose and eye preparations, feminine health, pain and respiratory diseases among others. Adcock Ingram also supplies critical care products, including blood collection products, intravenous solutions and renal dialysis systems. It operates three manufacturing facilities, namely, high volume liquids facility, tablet and capsule facility and critical care facility. The company supplies its products to both the private and public sectors of the market. Adcock Ingram is headquartered in Midrand, South Africa.

Scope

Detailed information on Adcock Ingram Holdings Ltd required for business and competitor intelligence needs

A study of the major internal and external factors affecting Adcock Ingram Holdings Ltd in the form of a SWOT analysis

An in-depth view of the business model of Adcock Ingram Holdings Ltd including a breakdown and examination of key business segments

News about Adcock Ingram Holdings Ltd, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Adcock Ingram Holdings Ltd and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Adcock Ingram Holdings Ltd as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Adcock Ingram Holdings Ltds business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Starwin Products Ltd

Rosemont Pharmaceuticals Ltd

Imbalie Beauty Limited

Herbal Africa

SA Natural Products (Pty) Ltd

Natural Carotenoids South Africa (Pty) Ltd

Nutritional Holdings Ltd

Aspen Pharmacare Holdings Ltd

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1 - About the Company 6

Adcock Ingram Holdings Ltd - Key Facts 6

Adcock Ingram Holdings Ltd - Key Employees 7

Adcock Ingram Holdings Ltd - Key Employee Biographies 8

Adcock Ingram Holdings Ltd - Major Products and Services 9

Adcock Ingram Holdings Ltd - History 10

Adcock Ingram Holdings Ltd - Company Statement 12

Adcock Ingram Holdings Ltd - Locations And Subsidiaries 13

Head Office 13

Other Locations & Subsidiaries 13

Joint Venture 14

Section 2 Company Analysis 15

Company Overview 15

Adcock Ingram Holdings Ltd - Business Description 16

Business Segment: Research and Development Services in India 16

Performance 16

Business Segment: Rest of Africa 16

Overview 16

Performance 16

Business Segment: Southern Africa 16

Overview 16

Performance 16

Adcock Ingram Holdings Ltd - Corporate Strategy 18

Adcock Ingram Holdings Ltd - SWOT Analysis 19

SWOT Analysis - Overview 19

Adcock Ingram Holdings Ltd - Strengths 19

Adcock Ingram Holdings Ltd - Weaknesses 20

Adcock Ingram Holdings Ltd - Opportunities 21

Adcock Ingram Holdings Ltd - Threats 22

Adcock Ingram Holdings Ltd - Key Competitors 23

Section 3 Company Financial Ratios 24

Financial Ratios - Capital Market Ratios 24

Financial Ratios - Annual Ratios 25

Performance Chart 28

Financial Performance 28

Financial Ratios - Interim Ratios 29

Financial Ratios - Ratio Charts 30

Section 4 Company’s Lifesciences Financial Deals and Alliances 31

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 32

Adcock Ingram Holdings Ltd, Recent Deals Summary 33

Section 5 Company’s Recent Developments 34

Aug 29, 2018: The Adcock Ingram reports a positive trading performance 34

Aug 29, 2018: Adcock Ingram Holdings - Group annual results and cash dividend declaration 36

Jan 29, 2018: Adcock Ingram Holdings: Change to the Board of Directors 38

Aug 25, 2017: Adcock Ingram Group year-end results reflect a satisfying trading performance and exceptional increase in trading profits as at 30 June 2017 39

Section 6 Appendix 40

Methodology 40

Ratio Definitions 40

About GlobalData 44

Contact Us 44

Disclaimer 44

List of Tables

List of Tables

Adcock Ingram Holdings Ltd, Key Facts 6

Adcock Ingram Holdings Ltd, Key Employees 7

Adcock Ingram Holdings Ltd, Key Employee Biographies 8

Adcock Ingram Holdings Ltd, Major Products and Services 9

Adcock Ingram Holdings Ltd, History 10

Adcock Ingram Holdings Ltd, Subsidiaries 13

Adcock Ingram Holdings Ltd, Joint Venture 14

Adcock Ingram Holdings Ltd, Key Competitors 23

Adcock Ingram Holdings Ltd, Ratios based on current share price 24

Adcock Ingram Holdings Ltd, Annual Ratios 25

Adcock Ingram Holdings Ltd, Annual Ratios (Cont…1) 26

Adcock Ingram Holdings Ltd, Annual Ratios (Cont…2) 27

Adcock Ingram Holdings Ltd, Interim Ratios 29

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 32

Adcock Ingram Holdings Ltd, Recent Deals Summary 33

Currency Codes 40

Capital Market Ratios 40

Equity Ratios 41

Profitability Ratios 41

Cost Ratios 42

Liquidity Ratios 42

Leverage Ratios 43

Efficiency Ratios 43

List of Figures

List of Figures

Adcock Ingram Holdings Ltd, Performance Chart (2014 – 2018) 28

Adcock Ingram Holdings Ltd, Ratio Charts 30

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 32

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports